Associations between remnant cholesterol and cardiovascular events in patients undergoing dialysis: a nationwide

Byung Sik Kim1, Hyun-Jin Kim1, Jiyeong Kim2,3

  • 1Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Republic of Korea.

Insights

High remnant cholesterol increases myocardial infarction risk in dialysis patients, independent of LDL-C. This finding highlights remnant cholesterol as a key factor for cardiovascular risk in this high-risk group.

Area of Science:

  • Cardiology
  • Nephrology
  • Biochemistry

Background:

  • Remnant cholesterol is a known cardiovascular disease risk factor.
  • Its role in dialysis patients, a high-risk group, is unclear.
  • This study investigates remnant cholesterol's prognostic value in end-stage kidney disease patients.

Purpose of the Study:

  • To evaluate the association between remnant cholesterol levels and cardiovascular outcomes.
  • To determine if remnant cholesterol is an independent risk factor for myocardial infarction and ischemic stroke in dialysis patients.

Main Methods:

  • Retrospective cohort study of 21,679 end-stage kidney disease patients on dialysis.
  • Data from the Korean National Health Insurance Service database (2009-2017).
  • Patients stratified by baseline remnant cholesterol quartiles; primary outcomes were myocardial infarction and ischemic stroke.

Main Results:

  • Elevated remnant cholesterol (Quartile 4 vs. 1) was associated with a 26% increased risk of myocardial infarction (HR 1.26).
  • A steady increase in myocardial infarction risk was observed with rising remnant cholesterol levels.
  • No significant association was found between remnant cholesterol and ischemic stroke risk.

Conclusions:

  • Elevated remnant cholesterol is independently associated with higher myocardial infarction risk in dialysis patients.
  • Remnant cholesterol may contribute to residual cardiovascular risk, independent of LDL-C.
  • These findings emphasize the importance of monitoring remnant cholesterol in patients with end-stage kidney disease.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...